The identification of these disorders depends on the ability of the clinician to recognize the clinically observable and identifiable features of the specific syndrome, with the diagnosis typically confirmed by targeted genetic testing (e.g., the mutation and repeat expansion screening of the FMR1 gene causing fragile X syndrome) [10,11]. The gene discussed is FMR1; the disease is fragile X syndrome.